Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT06402604
Eligibility Criteria:
Inclusion Criteria:
* Informed consent given
* Age \> or = 18 years
* Good understanding of Dutch language
* Preeclampsia in prior pregnancy, defined as the combination of gestational hypertension (≥140/90 mmHg, measured twice, six hours or more apart), and proteinuria (consistently ≥300mg/24 hours) after 20 weeks of pregnancy in previously normotensive women, according to International Society for the Study of Hypertension in Pregnancy (Brown, 2018).
* Normotensive at the time of baseline measurements
* Perceived Stress Scale score ≥ 16 or State-Trait Anxiety Inventory (STAI) score ≥ 41 or Edinburgh Postnatal Depression Scale (EPDS) score ≥ 10
Exclusion Criteria:
* Pre-existent diabetes mellitus, autoimmune disease, HIV positivity or overt cardio-vascular disease.
* Use of medication or supplements that might affect the cardiovascular system
* (Physical) inabilities to complete 12 weeks of moderate exercise training
* Currently involved in psychological therapy or mindfullness training.
* Pregnancy
* Women who intend to become pregnant within 12 weeks after baseline assessment
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06402604
Study Brief:
Protocol Section:
NCT06402604